Department of Allergy and Respirology, Hiratsuka City Hospital, Kanagawa, Japan.
Department of Respirology, National Hospital Organization Yokohama Medical Center, Yokohama, Japan.
J Asthma. 2023 Dec;60(12):2233-2242. doi: 10.1080/02770903.2023.2225618. Epub 2023 Jun 30.
Many studies have reported a poor prognosis for eosinophilic granulomatosis with polyangiitis (EGPA) patients with cardiac involvement.
A woman developed EGPA at 37 years of age, with weight loss, numbness in the right upper and lower extremities, muscle weakness, skin rash, abdominal pain, chest pain, an increased peripheral blood eosinophil count (4165/µL), and necrotizing vasculitis on peroneal nerve biopsy. The patient was treated with prednisolone, immunosuppressants, intravenous immune globulin, and mepolizumab, but she experienced many relapses, with chest pain, abdominal pain, numbness, and paralysis, over a long period. The patient died from aspiration pneumonia at 71 years of age after undergoing left total hip arthroplasty for left hip neck fracture.
Autopsy showed bronchopneumonia in the lower lung lobes on both sides, as well as infiltration of inflammatory cells, including neutrophils and lymphocytes. There was no evidence of active vasculitis in either the lung or colon. At autopsy the heart showed predominantly subendocardial fibrosis and fatty infiltration, but no active vasculitis or eosinophilic infiltration.
To our knowledge, there have been no autopsy reports of EGPA patients who have survived for 34 years with recurrent cardiac lesions. In this case, the cardiac involvement (active vasculitis and eosinophilic infiltration) had improved by the time of death.
许多研究报告称,伴有心脏受累的嗜酸性肉芽肿性多血管炎(EGPA)患者预后不良。
一名 37 岁女性发生 EGPA,出现体重减轻、右上、下肢麻木、肌无力、皮疹、腹痛、胸痛、外周血嗜酸性粒细胞计数升高(4165/µL)和腓肠神经活检的坏死性血管炎。该患者接受泼尼松龙、免疫抑制剂、静脉注射免疫球蛋白和美泊利珠单抗治疗,但长期经历多次复发,出现胸痛、腹痛、麻木和瘫痪。该患者在因左侧髋颈骨折行左侧全髋关节置换术后因吸入性肺炎于 71 岁时死亡。
尸检显示双侧下肺叶支气管肺炎,伴有中性粒细胞和淋巴细胞等炎症细胞浸润。肺和结肠均无活动性血管炎的证据。尸检时心脏表现为主要为心内膜下纤维化和脂肪浸润,但无活动性血管炎或嗜酸性粒细胞浸润。
据我们所知,尚无 EGPA 患者存活 34 年并伴有复发性心脏病变的尸检报告。在本例中,心脏受累(活动性血管炎和嗜酸性粒细胞浸润)在死亡时已得到改善。